Bruce Jackson
Stock Analyst at Benchmark
(1.01)
# 3,659
Out of 4,858 analysts
128
Total ratings
27.87%
Success rate
-20.86%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.61 | +349.79% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $2.67 | +424.34% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.59 | +404.54% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $4.26 | +674.65% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $2.67 | +761.42% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $61.70 | +29.66% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $7.84 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $56.18 | +15.70% | 7 | Jan 13, 2025 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.56 | - | 3 | Nov 22, 2024 | |
| UNCY Unicycive Therapeutics | Reiterates: Speculative Buy | $3 | $0.53 | +463.80% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.92 | +36.61% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.25 | +140.00% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.05 | +143.90% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $0.75 | +3,894.67% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $4.53 | +1,224.50% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.84 | +1,923.81% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.00 | +2,303.61% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1 | $3.02 | -66.89% | 2 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.80 | +78.57% | 5 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.82 | +508.27% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.60 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $18.17 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.59 | +22,184.12% | 1 | Aug 8, 2022 |
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.61
Upside: +349.79%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $2.67
Upside: +424.34%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.59
Upside: +404.54%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $4.26
Upside: +674.65%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $2.67
Upside: +761.42%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $61.70
Upside: +29.66%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.84
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $56.18
Upside: +15.70%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.56
Upside: -
Unicycive Therapeutics
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.53
Upside: +463.80%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.92
Upside: +36.61%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.25
Upside: +140.00%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.05
Upside: +143.90%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $0.75
Upside: +3,894.67%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $4.53
Upside: +1,224.50%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.84
Upside: +1,923.81%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.00
Upside: +2,303.61%
May 29, 2024
Reiterates: Speculative Buy
Price Target: $1
Current: $3.02
Upside: -66.89%
Apr 15, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.80
Upside: +78.57%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.82
Upside: +508.27%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.60
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $18.17
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.59
Upside: +22,184.12%